e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Novel mechanisms for established drugs for asthma and COPD management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Aclidinium bromide reduces extracellular matrix deposition by COPD-derived mesenchymal cells
C. Lambers, Y. Qi, E. Papakonstantinou, E. Schuller, M. Roth, L. H. Block (Wien, Austria; Basel, Austria, Switzerland; Thessaloniki, Greece)
Source:
Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Session:
Novel mechanisms for established drugs for asthma and COPD management
Session type:
Oral Presentation
Number:
3036
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Lambers, Y. Qi, E. Papakonstantinou, E. Schuller, M. Roth, L. H. Block (Wien, Austria; Basel, Austria, Switzerland; Thessaloniki, Greece). Aclidinium bromide reduces extracellular matrix deposition by COPD-derived mesenchymal cells. Eur Respir J 2013; 42: Suppl. 57, 3036
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Respiratory sequelae of preterm birth across the life span
Time to breathe: Challenges in the successful management of asthma during conception, pregnancy and delivery
Related content which might interest you:
Pirfenidone induced inhibition of p38 downregulates procoagulant microparticle generation by human alveolar epithelia cells
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Disease-derived extracellular matrix scaffolds instruct the transdifferentiation and migration of lung fibroblasts
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Milan PM10 induces the release of microparticles by human mononuclear cells
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Complex extracellular matrix modulates neutrophil migration
in vitro
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Evaluation of nanoparticles in human lung fibroblasts and PCLS
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016
Aclidinium bromide reduces epithelial-mesenchymal transition of human COPD epithelial cells
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
BIBF1120 inhibits fibroblasts proliferation and production of the extracellular matrix protein fibulin-1
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Promotional effect of 27-hydroxycholesterol in the release of matrix metalloproteinases by lung fibroblasts
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
PBI-compound, a novel first-in-class anti-fibrotic compound, inhibits CTGF and collagen production in murine and human fibroblasts, and reduces lung fibrosis in the bleomycin-induced lung fibrosis model
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
Late Breaking Abstract - 3D culturing mesenchymal stem cells in lung extracellular matrix hydrogels affects their homing potential
Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro
Year: 2020
Graphene compounds modulate autophagy combined with PU.1 change in the macrophages
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
The role of amiloride sensitive epithelial sodium channel (ENaC) in cell migration of mesothelioma cells is dependent on the cell type and the extracellular matrix
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Inhibition of matrix metalloproteinase-13 reduces antigen-presenting functions of murine dendritic cells
in vitro
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Inhibition of matrix metalloproteinase-2 activity by propranolol in immunocompetent cells
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
LATE-BREAKING ABSTRACT: Do mesenchymal stromal cells provide an organ-specific tissue niche? – A proteomic matrisome characterization
Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung
Year: 2016
Encapsulation of vinorelbine in polymeric nanoparticles improves efficacy in cancer cells and reduces inflammation in non-cancer cells
Source: International Congress 2016 – Late-breaking translational research in lung cancer
Year: 2016
The cytotoxicity of carbon black nanoparticles depends on their surface modification
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Effect of simvastatin on steroid-resistence in human epithelial cultured cells: A preliminary study
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Lung extracellular matrix hydrogel for 3D bioprinting of lung mesenchymal stem cells
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept